Dr. Pfaller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
# C606gh
Iowa City, IA 52242
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1979 - 1983- Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1976 - 1977
- Washington University in St. Louis School of MedicineClass of 1976
Certifications & Licensure
American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 17 citationsSurveillance of omadacycline activity tested against clinical isolates from the United States: Report from the SENTRY Antimicrobial Surveillance Program, 2019: Omadacy...Michael A. Pfaller, Michael D. Huband, Dee Shortridge, Robert K. Flamm
Journal of Global Antimicrobial Resistance. 2021-11-11 - 11 citationsCeftolozane-Tazobactam Activity Against Clinical Isolates of Pseudomonas aeruginosa from ICU Patients with Pneumonia: United States, 2015-2018.Michael A. Pfaller, Dee Shortridge, Kelly A Harris, Mark W Garrison, C Andrew DeRyke
International Journal of Infectious Diseases. 2021-09-28 - 10 citationsIn vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 yearsMichael A. Pfaller, Cecilia G Carvalhaes, Shawn A. Messer, Paul R. Rhomberg, Mariana Castanheira
Diagnostic Microbiology and Infectious Disease. 2021-07-01
Other
- Antifungal susceptibility testingPfaller MA
http://www.uptodate.com/contents/antifungal-susceptibility-testing
UpToDate, Wolters Kluwer Health - 2012-09-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
